Aesch, Switzerland

Alissa Karyne Da Silva

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Weleda Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alissa Karyne Da Silva. Retrieved from https://idiyas.com/inventor/alissa-karyne-da-silva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alissa Karyne Da Silva: Cosmetic Innovation at Weleda

Introduction

Alissa Karyne Da Silva is an inventor based in Aesch, Switzerland, and is associated with Weleda AG. Her patent work concerns cosmetic applications of plant-derived ingredients.

Latest Patents

Da Silva is named on 1 patent: “Cosmetic Composition Containing an Extract from Opuntia ficus-indica.” The invention describes a cosmetic composition containing a hydrocolloidal extract in which mucilages are selectively enriched. It also addresses the extract itself, a process for preparing it, and its use, particularly in cosmetics.

Career Highlights

Da Silva’s listed patent reflects research into the preparation and cosmetic use of an extract from Opuntia ficus-indica. The work focuses on selectively enriching mucilages in a hydrocolloidal extract.

Collaborations

Her listed coworkers include Daniel Heizler and Meike Schmitt. The patent information connects her work with Weleda AG.

Conclusion

Alissa Karyne Da Silva’s patent highlights an approach to cosmetic innovation based on a selectively enriched plant extract and its potential applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…